Direct isolation of donor-derived CMV-specific T-cells and their adoptive transfer for treatment or prophylaxis of CMV infection following allogeneic HSCT

被引：0
|
作者：
Lowdell, M. W. [1 ]
Thomson, K. [1 ]
Armoogum, J. [1 ]
Pang, K. [1 ]
Samuel, E. [1 ]
Desborough, M. [1 ]
Mackinnon, S. [1 ]
机构：
[1] Royal Free & UCL Med Sch, London, England
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [31] Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease
    Hobeika, A. C.
    Osada, T.
    Serra, D.
    Peplinski, S.
    Hanson, K.
    Tanaka, Y.
    Niedzwiecki, D.
    Chao, N.
    Rizzieri, D.
    Lyerly, H. K.
    Clay, T.
    Morse, M. A.
    CYTOTHERAPY, 2008, 10 (03) : 289 - 302
  • [32] Monitoring with tetramers enables detection of persistent recipient-derived CMV-specific T-cells
    Borchers, S.
    Luther, S.
    Lips, U.
    Dammann, E.
    Buchholz, S.
    Dobbelstein, C.
    Schmidtke, J.
    Koehl, U.
    Stadler, M.
    Krauter, J.
    Ganser, A.
    Mischak-Weissinger, E.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S26 - S26
  • [33] Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
    Neuenhahn, M.
    Albrecht, J.
    Odendahl, M.
    Schlott, F.
    Doessinger, G.
    Schiemann, M.
    Lakshmipathi, S.
    Martin, K.
    Bunjes, D.
    Harsdorf, S.
    Weissinger, E. M.
    Menzel, H.
    Verbeek, M.
    Uharek, L.
    Kroeger, N.
    Wagner, E.
    Kobbe, G.
    Schroeder, T.
    Schmitt, M.
    Held, G.
    Herr, W.
    Germeroth, L.
    Bonig, H.
    Tonn, T.
    Einsele, H.
    Busch, D. H.
    Grigoleit, G. U.
    LEUKEMIA, 2017, 31 (10) : 2161 - 2171
  • [34] Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
    M Neuenhahn
    J Albrecht
    M Odendahl
    F Schlott
    G Dössinger
    M Schiemann
    S Lakshmipathi
    K Martin
    D Bunjes
    S Harsdorf
    E M Weissinger
    H Menzel
    M Verbeek
    L Uharek
    N Kröger
    E Wagner
    G Kobbe
    T Schroeder
    M Schmitt
    G Held
    W Herr
    L Germeroth
    H Bonig
    T Tonn
    H Einsele
    D H Busch
    G U Grigoleit
    Leukemia, 2017, 31 : 2161 - 2171
  • [35] CMV INFECTION WITH SIGHT THREATENING CMV RETINITIS REFRACTORY TO CONVENTIONAL TREATMENT: SALVAGE THERAPY WITH AUTOLOGOUS CMV-SPECIFIC T CELLS - A CASE REPORT
    Herrmann, M.
    Gary, R.
    Bosch, J.
    Winkler, J.
    Schiffer, M.
    Opgenoorth, M.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 48 - 48
  • [36] GENERATION OF CLINICAL-GRADE CMV-SPECIFIC T-CELLS: T-CELL DONOR SELECTION AND MANUFACTURING OF T CELLS
    Tischer, S.
    Priesner, C.
    Arseniev, L.
    Aleksandrova, K.
    Goudeva, L.
    Heuft, H. -G.
    Maecker-Kolhoff, B.
    Blasczyk, R.
    Koehl, U.
    Eiz-Vesper, B.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S331 - S332
  • [37] The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor
    Scheinberg, Phillip
    Melenhorst, Jan J.
    Brenchley, Jason M.
    Hill, Brenna J.
    Hensel, Nancy F.
    Chattopadhyay, Pratip K.
    Roederer, Mario
    Picker, Louis J.
    Price, David A.
    Barrett, A. John
    Douek, Daniel C.
    BLOOD, 2009, 114 (24) : 5071 - 5080
  • [38] GENERATION OF CLINICAL-GRADE CMV-SPECIFIC T-CELLS: T-CELL DONOR SELECTION AND MANUFACTURING OF T CELLS
    Tischer, Sabine
    Priesner, Christoph
    Arseniev, Lubomir
    Goudeva, Lilia
    Aleksandrova, Krasimira
    Heuft, Hans-Gert
    Figueiredo, Constanca
    Maecker-Kolhoff, Britta
    Blasczyk, Rainer
    Koehl, Ulrike
    Eiz-Vesper, Britta
    TISSUE ANTIGENS, 2014, 84 (01): : 45 - 46
  • [39] Effective recovery of functional CD4+CMV-specific helper T-cells in the presence of CMV-specific CD8+T-cells is pivotal for prevention of recurrent CMV reactivation following allogeneic stem cell transplantation (SCT)
    Gratama, JW
    Brooimans, RA
    Niesters, H
    Southwick, PC
    Sullivan, LA
    Van Doornum, G
    Löwenberg, B
    Cornelissen, JJ
    CYTOMETRY PART A, 2004, 59A (01): : 34 - 34
  • [40] CMV-Specific CD4+ T Cells in CMV-IgG-Seronegative Individuals Protect from CMV Viremia Following Transplantation with a CMV-Seropositive Donor Kidney
    Litjens, N.
    Huang, L.
    Dedeoglu, B.
    Meijers, R.
    Betjes, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 520 - 521
12345